These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3732080)

  • 1. Bronchopulmonary infection due to B. catarrhalis. Clinical features and therapeutic response.
    McLeod DT; Ahmad F; Croughan MJ; Calder MA
    Drugs; 1986; 31 Suppl 3():109-12. PubMed ID: 3732080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchopulmonary infection due to Branhamella catarrhalis.
    McLeod DT; Ahmad F; Power JT; Calder MA; Seaton A
    Br Med J (Clin Res Ed); 1983 Nov; 287(6403):1446-7. PubMed ID: 6416451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence and antibiotic susceptibility of Branhamella catarrhalis in respiratory infections.
    Calder MA; Croughan MJ; McLeod DT; Ahmad F
    Drugs; 1986; 31 Suppl 3():11-6. PubMed ID: 3488189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical interpretation of beta-lactamase-producing strains of Branhamella catarrhalis in sputum Gram's stain and culture.
    Robinson A; Johnson PC; Griffith SB
    Am J Clin Pathol; 1987 Apr; 87(4):498-503. PubMed ID: 3548321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections.
    Slevin NJ; Aitken J; Thornley PE
    Lancet; 1984 Apr; 1(8380):782-3. PubMed ID: 6143094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Isolation of Branhamella catarrhalis from sputum and clinical features of bronchopulmonary infection due to Branhamella catarrhalis].
    Kinoshita A; Mukae H; Takase T; Ishino T; Kohno S; Kanda T; Yamaguchi K; Hirota M; Hara K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jun; 28(6):875-81. PubMed ID: 2120499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moraxella catarrhalis respiratory infection in adults.
    Chin NK; Kumarasinghe G; Lim TK
    Singapore Med J; 1993 Oct; 34(5):409-11. PubMed ID: 8153687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease.
    Nicotra B; Rivera M; Luman JI; Wallace RJ
    Arch Intern Med; 1986 May; 146(5):890-3. PubMed ID: 3963981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis. Preliminary report.
    Thornley PE; Aitken JM; Nichol GM; Slevin NJ
    Drugs; 1986; 31 Suppl 3():113-4. PubMed ID: 3525087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid.
    Ninane G; Joly J; Kraytman M; Piot P
    Lancet; 1978 Jul; 2(8083):257. PubMed ID: 79045
    [No Abstract]   [Full Text] [Related]  

  • 11. [Branhamella catarrhalis in infectious pathology of the respiratory tract].
    Le Faou A; Rio A
    Presse Med; 1983 Sep; 12(33):2035-7. PubMed ID: 6226017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].
    Texier-Maugein J; Escoubas J; Fouche J; Mormede M
    Pathol Biol (Paris); 1988 May; 36(5):540-3. PubMed ID: 3136431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Branhamella catarrhalis respiratory infections in The Netherlands.
    Maesen FP; Davies BI
    Drugs; 1986; 31 Suppl 3():83-6. PubMed ID: 3732084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998.
    Mikucka A; Janicka G; Krawiecka D; Kochanowska J
    Med Sci Monit; 2000; 6(2):300-4. PubMed ID: 11208326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of Branhamella catarrhalis isolates from bronchopulmonary infections.
    Ahmad F; McLeod DT; Croughan MJ; Calder MA
    Antimicrob Agents Chemother; 1984 Sep; 26(3):424-5. PubMed ID: 6508272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Branhamella catarrhalis as an indirect pathogen.
    Wardle JK
    Drugs; 1986; 31 Suppl 3():93-6. PubMed ID: 3732085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in bronchopulmonary infection due to branhamella catarrhalis.
    McLeod DT; Ahmad F; Capewell S; Croughan MJ; Calder MA; Seaton A
    Br Med J (Clin Res Ed); 1986 Apr; 292(6528):1103-5. PubMed ID: 3084017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infections.
    Saito A; Yamaguchi K; Shigeno Y; Kohno S; Shigeno H; Kusano N; Dotsu Y; Hara K
    Drugs; 1986; 31 Suppl 3():87-92. PubMed ID: 3488201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of Branhamella catarrhalis in bronchopulmonary infection--a case-control study.
    Yuen KY; Seto WH; Ong SG
    J Infect; 1989 Nov; 19(3):251-6. PubMed ID: 2513358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenicity of Branhamella catarrhalis.
    Schreiner A
    Acta Otolaryngol Suppl; 1984; 407():40-2. PubMed ID: 6333774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.